You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API brigatinib

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing brigatinib

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Takeda Pharmaceuticals America Inc	ALUNBRIG	brigatinib	63020-113	CELLULOSE, MICROCRYSTALLINE	2035-11-10
Takeda Pharmaceuticals America Inc	ALUNBRIG	brigatinib	63020-113	LACTOSE MONOHYDRATE	2035-11-10
Takeda Pharmaceuticals America Inc	ALUNBRIG	brigatinib	63020-113	MAGNESIUM STEARATE	2035-11-10
Takeda Pharmaceuticals America Inc	ALUNBRIG	brigatinib	63020-113	SILICON DIOXIDE	2035-11-10
Takeda Pharmaceuticals America Inc	ALUNBRIG	brigatinib	63020-113	SODIUM STARCH GLYCOLATE TYPE A POTATO	2035-11-10
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for brigatinib

Excipient focus: CELLULOSE, MICROCRYSTALLINE

brigatinib drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Takeda Pharmaceuticals America Inc	brigatinib	63020-113
>Company	>Ingredient	>NDC

brigatinib drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

brigatinib drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Takeda Pharmaceuticals America Inc	brigatinib	63020-113
>Company	>Ingredient	>NDC

brigatinib drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

brigatinib drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Takeda Pharmaceuticals America Inc	brigatinib	63020-113
>Company	>Ingredient	>NDC

brigatinib drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

brigatinib drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Takeda Pharmaceuticals America Inc	brigatinib	63020-113
>Company	>Ingredient	>NDC

brigatinib drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

brigatinib drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Takeda Pharmaceuticals America Inc	brigatinib	63020-113
>Company	>Ingredient	>NDC

brigatinib drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.